Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Starbucks Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Starbucks Corp trades at $94 (market cap $104.88B). The key difference: Starbucks Corp is far larger — about 107.8× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Starbucks Corp pays a 2.74% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Starbucks Corp for 190 Days on average.
| MRVI | SBUX | |
|---|---|---|
Market Cap | $972.90M | $104.88B |
Volume | 4,325,710 | 9,749,448 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.00 | $108.55 |
52-Week Low | $2.83 | $79.60 |
Typical Hold Time | 0 Days | 190 Days |
Enterprise Value | $1.08B | $123.70B |
Dividend Yield | — | 2.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Starbucks (SBUX) trades at $92.00, down 0.31% on the day, with technical indicators showing bearish momentum. The company reported mixed quarterly results, missing Q4 2025 EPS estimates but beating in Q1 and Q2 2026. Recent news highlights store closures and strategic restructuring, while analyst consensus remains positive with a $115.50 price target. Financial trends show revenue growth to $37.18B in 2025 but declining net income margins from 11.46% in 2023 to 4.99% in 2025.
SBUX faces execution risks from store optimization and labor relations, but strong brand equity and analyst buy ratings suggest long-term recovery potential. The stock's high P/E ratio of 53.18 indicates premium valuation expectations. Near-term pressure from restructuring costs contrasts with dividend stability and international expansion opportunities through partnerships in Asia.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
